51
Views
14
CrossRef citations to date
0
Altmetric
Review

Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients

, &
Pages 1051-1067 | Published online: 28 Oct 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ke Li, Baoan Chen, Lin Xu, Jifeng Feng, Guohua Xia, Jian Cheng, Jun Wang, Feng Gao & Xuemei Wang. (2013) Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivo. International Journal of Nanomedicine 8, pages 1867-1877.
Read now

Articles from other publishers (13)

Fu-Ju Chou, ChangYi Lin, Hao Tian, WanYing Lin, Bosen You, Jieyang Lu, Deepak Sahasrabudhe, Chi-Ping Huang, Vanessa Yang, Shuyuan Yeh, Yuanjie Niu & Chawnshang Chang. (2020) Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer. Cell Death & Disease 11:11.
Crossref
Ali Sakhawat, Ling Ma, Tahir Muhammad, Aamir Ali Khan, Xuechai Chen & Yinghui Huang. (2019) A tumor targeting oncolytic adenovirus can improve therapeutic outcomes in chemotherapy resistant metastatic human breast carcinoma. Scientific Reports 9:1.
Crossref
Luca Falzone, Salvatore Salomone & Massimo Libra. (2018) Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. Frontiers in Pharmacology 9.
Crossref
Junlian Gu, Yang Li, Jun Zeng, Bo Wang, Kun Ji, Yufeng Tang & Qing Sun. (2017) Knockdown of HIF-1α by siRNA-expressing plasmid delivered by attenuated Salmonella enhances the antitumor effects of cisplatin on prostate cancer. Scientific Reports 7:1.
Crossref
Deuk-Won Jo, Young-Kyun Kim & Pil-Young Yun. (2016) The influence of p53 mutation status on the anti-cancer effect of cisplatin in oral squamous cell carcinoma cell lines. Journal of the Korean Association of Oral and Maxillofacial Surgeons 42:6, pages 337.
Crossref
Kun-Chun Chiang, Ke-Hung Tsui, Li-Chuan Chung, Chun-Nan Yeh, Tsui-Hsia Feng, Wen-Tsung Chen, Phei-Lang Chang, Hou-Yu Chiang & Horng-Heng Juang. (2014) Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways. Scientific Reports 4:1.
Crossref
Junlian Gu, Yufeng Tang, Yanan Liu, Hua Guo, Yue Wang, Lu Cai, Yang Li & Bo Wang. (2014) Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo. Cancer Letters 343:2, pages 200-209.
Crossref
Tao Jiang, Changdong Zhou, Junlian Gu, Yanan Liu, Lijing Zhao, Wei Li, Guanjun Wang, Yang Li & Lu Cai. (2013) Enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated Salmonella carrying a plasmid co-expressing p53 gene and mdm2 siRNA. Cancer Letters 337:1, pages 133-142.
Crossref
Yong P Ma, Yang Yang, Shuang Zhang, Xiang Chen, Na Zhang, Wei Wang, Zhi X Cao, Yu Jiang, Xia Zhao, Yu Q Wei & Hong X Deng. (2010) Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP. Journal of Experimental & Clinical Cancer Research 29:1.
Crossref
Edmundo A. Rodriguez-Frias & William M. Lee. (2007) Cancer Chemotherapy I: Hepatocellular Injury. Clinics in Liver Disease 11:3, pages 641-662.
Crossref
Rafael RosellMariacarmela SantarpiaTeresa MoranMaria Fernanda Salazar, Diego Lucas KaenJose Luis Ramirez. (2007) Age-related genetic abnormalities: the Achilles’ heel for customizing therapy in elderly lung cancer patients. Personalized Medicine 4:1, pages 59-72.
Crossref
V. Gebbia, F. Oniga, R. Agueli & A. Paccagnella. (2006) Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin?. Annals of Oncology 17, pages ii83-ii87.
Crossref
A. Rossi & C. Gridelli. (2006) Chemotherapy of advanced non-small cell lung cancer in elderly patients. Annals of Oncology 17, pages ii58-ii60.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.